Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Planning Adaptive Treatment by Longitudinal Response Assessment Implementing MR Imaging, Liquid Biopsy and Analysis of Microenvironment During Neoadjuvant Treatment of Rectal Cancer (PRIMO)

NCT05524012 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.

NCT NCT05524012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05524012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Planning Adaptive Treatment by Longitudinal Response Assessment Implementing MR Imaging, Liquid Biopsy and Analysis of Microenvironment During Neoadjuvant Treatment of Rectal Cancer (PRIMO)
Lead sponsor
Jena University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
November 30, 2022
Completion date
September 30, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adaptive treatment, locally advanced rectal carcinoma, neoadjuvant treatment, radiotherapy